This material is provided in a sealed container to maintain integrity and consistency and is intended exclusively for in vitro and analytical laboratory applications conducted by qualified professionals
For individuals taking glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity), or the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound), maintaining adequate magnesium status may be particularly important
Primary outcomes were risk of developing AP, need for parenteral nutrition, systemic complications (sepsis, systemic inflammatory response syndrome, shock, mechanical ventilation, acute kidney injury), and local pancreatic complications
doi: 10.1007/s13555-023-00915-1 [DOI] [PMC free article] [PubMed] [Google Scholar] 6.Pitowska Z, Nowicka D, Szepietowski JC
These are interconnected fields